EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GREM1/FGFR1-activated myofibroblasts induce immunosuppression and accelerate metastasis in high-grade serous ovarian cancer

Runrong Li, Xizhan Huang, Yue Chen iD, Xiaowen Chen, Yue Yang, Yurui Liu, Binyi Bai, Fanliang Meng, Yan Li, Yunshan Ning iD

Proceedings of the National Academy of Sciences · 16.06.2026 · 123 (24)

DOI: 10.1073/pnas.2529786123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.06.2026. Verfasst von Runrong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Myofibroblasts, Intercellular Signaling Peptides and Proteins, Cystadenocarcinoma, Serous. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Joint effect of cancer-associated fibroblasts (CAFs) and regulatory T cells (Tregs) can drive immunosuppression in high-grade serous ovarian cancer (HGSOC), thereby promoting tumor metastasis and limiting the clinical benefit of PD-1/PD-L1 blockade. However, the mechanistic crosstalk between CAFs and Tregs remains unclear. By integrating bulk RNA-seq, single-cell RNA-seq datasets, and spatial transcriptomics datasets with functional assays, we identified a population of TGF-β1-driven Gremlin1 (GREM1) + myofibroblastic CAFs (myCAFs) enriched in HGSOC metastatic lesions. These GREM1 + myCAFs activated the FGFR1-MAPKs-NFκB-TDO2-kynurenine axis via autocrine signaling, promoting tumor growth, metastasis, and immune evasion characterized by the infiltration of CD4 + Tregs and dysfunctional CD8 + T cells. GREM1 knockdown suppressed tumor metastasis, restored antitumor T cells response, remodeled CAF subtype composition and potentiated anti-PD-1 therapy efficacy. This study highlights the pro-metastatic role of GREM1 + myCAFs across multiple tumors and provides a rationale for combining anti-PD-1 therapy for metastatic HGSOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsMyofibroblastsIntercellular Signaling Peptides and ProteinsCystadenocarcinoma, SerousFemaleHumansAnimalsCancer-Associated FibroblastsT-Lymphocytes, RegulatoryMiceNeoplasm MetastasisCell Line, TumorTransforming Growth Factor beta1Signal TransductionGene Expression Regulation, NeoplasticImmune Tolerance

Stichwörter der Autor:innen

Gremlin1immune evasionmetastasismyofibroblastsovarian cancer

Substanzen

GREM1 protein, humanIntercellular Signaling Peptides and ProteinsTransforming Growth Factor beta1

Autor:innen und Institutionen

  • School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
  • Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, Southern Medical University, Guangzhou 510515, China.
  • The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
  • Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

ORCID-Profile: Yue Chen, Yunshan Ning

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)

Zitieren

APA

Li, R., Huang, X., Chen, Y., Chen, X., Yang, Y., Liu, Y., Bai, B., Meng, F., Li, Y., & Ning, Y. (2026). GREM1/FGFR1-activated myofibroblasts induce immunosuppression and accelerate metastasis in high-grade serous ovarian cancer. Proceedings of the National Academy of Sciences, 123(24). https://doi.org/10.1073/pnas.2529786123

Vancouver

Li R, Huang X, Chen Y, Chen X, Yang Y, Liu Y, et al. GREM1/FGFR1-activated myofibroblasts induce immunosuppression and accelerate metastasis in high-grade serous ovarian cancer. Proceedings of the National Academy of Sciences. 2026;123(24). doi:10.1073/pnas.2529786123

BibTeX
@article{Li2026,
  author = {Li, Runrong and Huang, Xizhan and Chen, Yue and Chen, Xiaowen and Yang, Yue and Liu, Yurui and Bai, Binyi and Meng, Fanliang and Li, Yan and Ning, Yunshan},
  title = {GREM1/FGFR1-activated myofibroblasts induce immunosuppression and accelerate metastasis in high-grade serous ovarian cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {24},
  doi = {10.1073/pnas.2529786123}
}
Kostenlos starten →